Cardiovascular effect of normalizing the hematocrit level during erythropoietin therapy in predialysis patients with chronic renal failure.
Am J Kidney Dis. 2000 Feb;35(2):250-6. doi: 10.1016/s0272-6386(00)70334-9.
Am J Kidney Dis. 2000.
PMID: 10676724
Clinical Trial.